EP Patent

EP2848243A1 — Organic compound nanopowder, production method therefor, and suspension

Assigned to Activus Pharma Co Ltd · Expires 2015-03-18 · 11y expired

What this patent protects

OBJECT The object of present invention is to provide an organic compound nano-powder conveniently, with low cost and with less contamination of impurities to be removed. MEANS FOR SOLVING The present inventions relate an organic compound nano-powder comprising a…

USPTO Abstract

OBJECT The object of present invention is to provide an organic compound nano-powder conveniently, with low cost and with less contamination of impurities to be removed. MEANS FOR SOLVING The present inventions relate an organic compound nano-powder comprising a granular organic compound with an average particle diameter of 500 nm or less and a 90%-diameters of less than 1500 nm and a carbohydrate compound comprising at least any one of a sugar and a sugar alcohol and with amount of 0.3 times or more by mass relative to amount of the organic compound, a method for producing the same, and a suspension having the organic compound dispersed in a liquid dispersion medium in which the organic compound is insoluble or poorly soluble.

Drugs covered by this patent

Patent Metadata

Patent number
EP2848243A1
Jurisdiction
EP
Classification
—
Expires
2015-03-18
Drug substance claim
No
Drug product claim
No
Assignee
Activus Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.